Compare PRME & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRME | MLEC |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 4.9M |
| IPO Year | 2022 | N/A |
| Metric | PRME | MLEC |
|---|---|---|
| Price | $4.16 | $0.42 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.31 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 131.3K |
| Earning Date | 11-07-2025 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,977,000.00 | N/A |
| Revenue This Year | $111.80 | $20.42 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | 170.36 |
| 52 Week Low | $1.11 | $0.39 |
| 52 Week High | $6.94 | $8.00 |
| Indicator | PRME | MLEC |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 36.36 |
| Support Level | $3.95 | $0.41 |
| Resistance Level | $4.42 | $0.48 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 76.72 | 24.66 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.